Functional and Therapeutic Analysis of Hepatitis C Virus NS3·4A Protease Control of Antiviral Immune Defense
Open Access
- 1 April 2007
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (14) , 10792-10803
- https://doi.org/10.1074/jbc.m610361200
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2Proceedings of the National Academy of Sciences, 2007
- Regulation of antiviral responses by a direct and specific interaction between TRAF3 and CardifThe EMBO Journal, 2006
- Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infectionProceedings of the National Academy of Sciences, 2006
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- VISA Is an Adapter Protein Required for Virus-Triggered IFN-β SignalingMolecular Cell, 2005
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005
- IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon inductionNature Immunology, 2005
- Evasion of intracellular host defence by hepatitis C virusNature, 2005
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004